These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8058006)

  • 21. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L3 acute lymphoblastic leukemia. Comparison with small noncleaved cell lymphoma involving the bone marrow.
    Dayton VD; Arthur DC; Gajl-Peczalska KJ; Brunning R
    Am J Clin Pathol; 1994 Feb; 101(2):130-9. PubMed ID: 8116566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Characteristics and Treatment Outcomes of Pediatric Patients with Non-Hodgkin Lymphoma in East Asia.
    Suh JK; Gao YJ; Tang JY; Jou ST; Lin DT; Takahashi Y; Kojima S; Jin L; Zhang Y; Seo JJ
    Cancer Res Treat; 2020 Apr; 52(2):359-368. PubMed ID: 31352772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.
    Bertini M; Freilone R; Vitolo U; Botto B; Ciotti R; Cinieri S; Di Nota A; Di Vito F; Levis A; Orsucci L; Pini M; Rota-Scalabrini D; Todeschini G; Resegotti L
    Leuk Lymphoma; 1996 Aug; 22(5-6):483-93. PubMed ID: 8882962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience.
    Cairo MS; Sposto R; Perkins SL; Meadows AT; Hoover-Regan ML; Anderson JR; Siegel SE; Lones MA; Tedeschi-Blok N; Kadin ME; Kjeldsberg CR; Wilson JF; Sanger W; Morris E; Krailo MD; Finlay JL
    Br J Haematol; 2003 Feb; 120(4):660-70. PubMed ID: 12588354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A collaborative study of children with lymphoblastic non-Hodgkin's lymphoma in China].
    ;
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):931-7. PubMed ID: 26887549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
    Burkhardt B; Zimmermann M; Oschlies I; Niggli F; Mann G; Parwaresch R; Riehm H; Schrappe M; Reiter A;
    Br J Haematol; 2005 Oct; 131(1):39-49. PubMed ID: 16173961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG).
    Hann IM; Eden OB; Barnes J; Pinkerton CR
    Br J Haematol; 1990 Nov; 76(3):359-64. PubMed ID: 2261346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
    Diviné M; Lepage E; Brière J; Pautier P; Dupriez B; Lederlin P; Mineur P; Tilly H; Blanc M; Audhuy B; Herbrecht R; Coiffier B; Reyes F
    J Clin Oncol; 1996 Jan; 14(1):240-8. PubMed ID: 8558204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study).
    Rahiman EA; Bakhshi S; Deepam Pushpam ; Ramamoorthy J; Das A; Ghara N; Kalra M; Kapoor G; Meena JP; Siddaigarhi S; Thulkar S; Sharma MC; Srinivasan R; Trehan A
    Pediatr Hematol Oncol; 2022 Aug; 39(5):391-405. PubMed ID: 34978257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
    Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive Chemotherapy Without Radiotherapy Gives More than 85% Event-Free Survival for Non-Hodgkin Lymphoma Without Central Nervous Involvement: A 6-Year Population-Based Study From the Nordic Society of Pediatric Hematology and Oncology.
    Márky I; Björk O; Forestier E; Jónsson ÓG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-560. PubMed ID: 27811620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactate dehydrogenase 5 expression in Non-Hodgkin lymphoma is associated with the induced hypoxia regulated protein and poor prognosis.
    Lu R; Jiang M; Chen Z; Xu X; Hu H; Zhao X; Gao X; Guo L
    PLoS One; 2013; 8(9):e74853. PubMed ID: 24086384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
    Bowman WP; Shuster JJ; Cook B; Griffin T; Behm F; Pullen J; Link M; Head D; Carroll A; Berard C; Murphy S
    J Clin Oncol; 1996 Apr; 14(4):1252-61. PubMed ID: 8648381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
    J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
    Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
    Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
    Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD
    J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.
    Burkhardt B; Oschlies I; Klapper W; Zimmermann M; Woessmann W; Meinhardt A; Landmann E; Attarbaschi A; Niggli F; Schrappe M; Reiter A
    Leukemia; 2011 Jan; 25(1):153-60. PubMed ID: 21030984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
    Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
    J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.